<DOC>
	<DOCNO>NCT00047554</DOCNO>
	<brief_summary>The purpose study monitor iris pigmentation change 5-year period patient open-angle glaucoma ocular hypertension . To eligible study , individual must experience iris pigmentation change previously dose TRAVATAN .</brief_summary>
	<brief_title>Study TRAVATAN Subjects With Iris Pigmentation Changes</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Inclusion : ï»¿Diagnosis openangle glaucoma ( without pseudoexfoliation pigment dispersion component ) ocular hypertension ; Has experience iris pigmentation change dose TRAVATAN ; Currently dose TRAVATAN ; Other protocoldefined inclusion criterion may apply . Exclusion : Any form glaucoma openangle glaucoma ( without pigment dispersion pseudoexfoliation component ) ocular hypertension ; Not currently use TRAVATAN ; Females childbearing potential pregnant , breastfeeding , use highly effective birth control measure ; History severe ocular pathology ( include severe dry eye ) ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>open-angle</keyword>
	<keyword>glaucoma</keyword>
	<keyword>ocular</keyword>
	<keyword>hypertension</keyword>
	<keyword>primary open-angle glaucoma</keyword>
	<keyword>iris</keyword>
	<keyword>pigmentation</keyword>
</DOC>